CEO Interview
Medigus: Successful Incubator of Israeli Tech Companies
Company Overview
An Israeli technology company, Medigus is focused on building innovative growth partnerships, primarily in advanced medical solutions, digital commerce, and electric vehicle (EV) markets.
Medigus’ medical-solutions segment includes ownership in Polyrizon Ltd., a clinical development biotech company specializing in the development of innovative nasal gels to provide preventative treatment against a wide range of biological assaults, including COVID-19, and ownership in ScoutCam Inc., a micro- imaging technology company.
Medigus’ affiliates in digital commerce include Gix Internet Ltd., a media-tech company, Jeffs' Brands Ltd., a high- growth consumer products company operating primarily on Amazon.com, Safee, a blockchain company focused on NFTs and other digital assets, and Eventer Technologies Ltd., a smart ticketing platform.
In the EV market, the Company’s portfolio of technology solution providers includes Charging Robotics Ltd., a wireless robotic charging system for EVs, and Revoltz Ltd., a designer and developer of micro-mobility EVs.
Contact Information:
RedChip.com | 1-800-REDCHIP (733-2447)
Disclosure
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law, RedChip Companies, Inc., our specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information).
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov.
Medigus (MDGS) is a client of RedChip Companies, Inc. MDGS agreed to pay RedChip Companies, Inc. a $70,000 monthly cash fee, beginning in January 2022, and 70,000 shares of MDGS Rule 144 stock for three months of RedChip investor awareness services.
Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. RedChip investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services.
Privacy Policy
Website Powered By
© 2022 Redchip Companies, Inc.